← Back to Search

Action Observation as a Rehabilitation Intervention for Stroke

N/A
Waitlist Available
Led By Veronica T Rowe, PhD, OTR/L
Research Sponsored by Georgia State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up arm and hand movement recorded in one day during the 3 blocks of physical performance of the srtt
Awards & highlights
No Placebo-Only Group

Summary

This trial investigates Action Observation (AO) as a way to help stroke survivors with mild to moderate arm and hand weakness. AO involves watching videos of normal movements to mentally practice and improve their own movements. The study aims to understand how eye gaze patterns during AO can enhance rehabilitation. AO has been studied for many years as a method to promote motor recovery in stroke patients by activating the mirror-neural system.

Eligible Conditions
  • Stroke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~eye gaze recorded in one day during the 3 blocks of video watching (action observation)
This trial's timeline: 3 weeks for screening, Varies for treatment, and eye gaze recorded in one day during the 3 blocks of video watching (action observation) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Arm and hand movement with the Serial Reaction Time Test (SRTT)
Eye gaze pattern

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Action observationExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Action observation
2021
N/A
~230

Find a Location

Who is running the clinical trial?

Georgia Institute of TechnologyOTHER
51 Previous Clinical Trials
5,610 Total Patients Enrolled
5 Trials studying Stroke
93 Patients Enrolled for Stroke
Georgia State UniversityLead Sponsor
62 Previous Clinical Trials
29,076 Total Patients Enrolled
1 Trials studying Stroke
116 Patients Enrolled for Stroke
Veronica T Rowe, PhD, OTR/LPrincipal InvestigatorGeorgia State University
~5 spots leftby Dec 2025